LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 30

Search options

  1. Article ; Online: Resolution of hepatic fibrosis after ZFN-mediated gene editing in the PiZ mouse model of human α1-antitrypsin deficiency.

    Li, Yanfeng / Guha, Chandan / Asp, Patrik / Wang, Xia / Tchaikovskya, Tatyana L / Kim, Kenneth / Mendel, Matthew / Cost, Gregory J / Perlmutter, David H / Roy-Chowdhury, Namita / Fox, Ira J / Conway, Anthony / Roy-Chowdhury, Jayanta

    Hepatology communications

    2023  Volume 7, Issue 3, Page(s) e0070

    Abstract: Background: α1-antitrypsin deficiency is most commonly caused by a mutation in exon-7 of SERPINA1 (SA1-ATZ), resulting in hepatocellular accumulation of a misfolded variant (ATZ). Human SA1-ATZ-transgenic (PiZ) mice exhibit hepatocellular ATZ ... ...

    Abstract Background: α1-antitrypsin deficiency is most commonly caused by a mutation in exon-7 of SERPINA1 (SA1-ATZ), resulting in hepatocellular accumulation of a misfolded variant (ATZ). Human SA1-ATZ-transgenic (PiZ) mice exhibit hepatocellular ATZ accumulation and liver fibrosis. We hypothesized that disrupting the SA1-ATZ transgene in PiZ mice by in vivo genome editing would confer a proliferative advantage to the genome-edited hepatocytes, enabling them to repopulate the liver.
    Methods: To create a targeted DNA break in exon-7 of the SA1-ATZ transgene, we generated 2 recombinant adeno-associated viruses (rAAV) expressing a zinc-finger nuclease pair (rAAV-ZFN), and another rAAV for gene correction by targeted insertion (rAAV-TI). PiZ mice were injected i.v. with rAAV-TI alone or the rAAV-ZFNs at a low (7.5×1010vg/mouse, LD) or a high dose (1.5×1011vg/mouse, HD), with or without rAAV-TI. Two weeks and 6 months after treatment, livers were harvested for molecular, histological, and biochemical analyses.
    Results: Two weeks after treatment, deep sequencing of the hepatic SA1-ATZ transgene pool showed 6%±3% or 15%±4% nonhomologous end joining in mice receiving LD or HD rAAV-ZFN, respectively, which increased to 36%±12% and 36%±12%, respectively, 6 months after treatment. Two weeks postinjection of rAAV-TI with LD or HD of rAAV-ZFN, repair by targeted insertion occurred in 0.10%±0.09% and 0.25%±0.14% of SA1-ATZ transgenes, respectively, which increased to 5.2%±5.0% and 33%±13%, respectively, 6 months after treatment. Six months after rAAV-ZFN administration, there was a marked clearance of ATZ globules from hepatocytes, and resolution of liver fibrosis, along with reduction of hepatic TAZ/WWTR1, hedgehog ligands, Gli2, a TIMP, and collagen content.
    Conclusions: ZFN-mediated SA1-ATZ transgene disruption provides a proliferative advantage to ATZ-depleted hepatocytes, enabling them to repopulate the liver and reverse hepatic fibrosis.
    MeSH term(s) Humans ; Animals ; Mice ; Gene Editing ; Zinc Finger Nucleases ; Liver Cirrhosis/genetics ; Liver Cirrhosis/therapy ; Hepatocytes ; Disease Models, Animal ; Intracellular Signaling Peptides and Proteins
    Chemical Substances Zinc Finger Nucleases (EC 3.1.-) ; Intracellular Signaling Peptides and Proteins
    Language English
    Publishing date 2023-02-27
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ISSN 2471-254X
    ISSN (online) 2471-254X
    DOI 10.1097/HC9.0000000000000070
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Hepatocyte-like cells derived from induced pluripotent stem cells.

    Roy-Chowdhury, Namita / Wang, Xia / Guha, Chandan / Roy-Chowdhury, Jayanta

    Hepatology international

    2016  Volume 11, Issue 1, Page(s) 54–69

    Abstract: The discovery that coordinated expression of a limited number of genes can reprogram differentiated somatic cells to induced pluripotent stem cells (iPSC) has opened novel possibilities for developing cell-based models of diseases and regenerative ... ...

    Abstract The discovery that coordinated expression of a limited number of genes can reprogram differentiated somatic cells to induced pluripotent stem cells (iPSC) has opened novel possibilities for developing cell-based models of diseases and regenerative medicine utilizing cell reprogramming or cell transplantation. Directed differentiation of iPSCs can potentially generate differentiated cells belonging to any germ layer, including cells with hepatocyte-like morphology and function. Such cells, termed iHeps, can be derived by sequential cell signaling using available information on embryological development or by forced expression of hepatocyte-enriched transcription factors. In addition to the translational aspects of iHeps, the experimental findings have provided insights into the mechanisms of cell plasticity that permit one cell type to transition to another. However, iHeps generated by current methods do not fully exhibit all characteristics of mature hepatocytes, highlighting the need for additional research in this area. Here we summarize the current approaches and achievements in this field and discuss some existing hurdles and emerging approaches for improving iPSC differentiation, as well as maintaining such cells in culture for increasing their utility in disease modeling and drug development.
    MeSH term(s) Animals ; Cell Culture Techniques/methods ; Cell Differentiation/physiology ; Cellular Reprogramming/physiology ; Hepatocytes/cytology ; Humans ; Induced Pluripotent Stem Cells/cytology ; Regenerative Medicine ; Signal Transduction
    Language English
    Publishing date 2016-08-17
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2270316-0
    ISSN 1936-0541 ; 1936-0533
    ISSN (online) 1936-0541
    ISSN 1936-0533
    DOI 10.1007/s12072-016-9757-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Drug- and Drug Abuse-Associated Hyperbilirubinemia: Experience With Atazanavir.

    Roy-Chowdhury, Jayanta / Roy-Chowdhury, Namita / Listowsky, Irving / Wolkoff, Allan W

    Clinical pharmacology in drug development

    2017  Volume 6, Issue 2, Page(s) 140–146

    Abstract: Hyperbilirubinemia is a common finding in individuals with a history of substance abuse. Although this may indicate a serious disorder of liver function, this is not always the case. An understanding of bilirubin formation, metabolism, and transport can ... ...

    Abstract Hyperbilirubinemia is a common finding in individuals with a history of substance abuse. Although this may indicate a serious disorder of liver function, this is not always the case. An understanding of bilirubin formation, metabolism, and transport can provide a helpful approach to dealing with these patients. This is typified by studies of patients treated with the antiretroviral drug atazanavir. Atazanavir has been associated with hyperbilirubinemia in as many as one-third of individuals for whom it has been prescribed, evoking concerns of hepatotoxicity. The studies in this report were designed to determine mechanisms by which this occurs. The data show that this drug inhibits the enzyme UDP-glucuronosyl transferase-1A1, responsible for conjugating bilirubin with glucuronic acid. This conjugation step is required for bilirubin excretion into bile, and when it is inhibited, bilirubin refluxes from the liver into the circulation, causing unconjugated hyperbilirubinemia. Other parameters of bilirubin formation, binding to albumin in the circulation, uptake into hepatocytes, and intracellular protein binding in hepatocytes were unaffected by atazanavir. The effect of atazanavir on serum bilirubin levels is reversible, consistent with lack of structural damage to the liver.
    Language English
    Publishing date 2017-03
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2649010-9
    ISSN 2160-7648 ; 2160-763X
    ISSN (online) 2160-7648
    ISSN 2160-763X
    DOI 10.1002/cpdd.314
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Induced pluripotent stem cells as a source of hepatocytes.

    Sauer, Vanessa / Roy-Chowdhury, Namita / Guha, Chandan / Roy-Chowdhury, Jayanta

    Current pathobiology reports

    2014  Volume 2, Issue 1, Page(s) 11–20

    Abstract: During the past decade, a series of discoveries has established the potential of the so called terminally differentiated cells to transition to more primitive progenitor cells. The dramatic demonstration of the ability to reprogram differentiated somatic ...

    Abstract During the past decade, a series of discoveries has established the potential of the so called terminally differentiated cells to transition to more primitive progenitor cells. The dramatic demonstration of the ability to reprogram differentiated somatic cells to induced pluripotent stem cells (iPSC) that can then give rise to cells of all three germ layers has opened the possibility of generating virtually any cell type in culture, from any given individual. Taking advantage of these concepts, researchers have generated iPSCs by reprogramming a wide variety of somatic cells. In addition to their practical implications, these studies have provided crucial insights into the mechanism of cell plasticity that underlies the transition from one cell type to another. Using concepts derived from research on embryological development, investigators have differentiated iPSCs to cells resembling hepatocytes in many ways. Such hepatocyte-like cells could be of enormous value in disease modeling, drug discovery and regenerative medicine. However, the currently available methods do not yield cells that fully reproduce the characteristics of adult primary hepatocytes. Thus generating hepatocytes from iPSCs is very much a work in progress. In addition to chronicling these exciting developments, this review will discuss the emergent new approaches to generating iPSCs, improving their differentiation to hepatocyte-like cells and maintaining the hepatocyte-like cells in culture for longer survival and better function.
    Language English
    Publishing date 2014-12-30
    Publishing country United States
    Document type Journal Article
    ISSN 2167-485X
    ISSN 2167-485X
    DOI 10.1007/s40139-013-0039-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Hepatocyte Transplantation: Quo Vadis?

    Barahman, Mark / Asp, Patrik / Roy-Chowdhury, Namita / Kinkhabwala, Milan / Roy-Chowdhury, Jayanta / Kabarriti, Rafi / Guha, Chandan

    International journal of radiation oncology, biology, physics

    2018  Volume 103, Issue 4, Page(s) 922–934

    Abstract: Orthotopic liver transplantation (OLT) has been effective in managing end-stage liver disease since the advent of cyclosporine immunosuppression therapy in 1980. The major limitations of OLT are organ supply, monetary cost, and the burden of lifelong ... ...

    Abstract Orthotopic liver transplantation (OLT) has been effective in managing end-stage liver disease since the advent of cyclosporine immunosuppression therapy in 1980. The major limitations of OLT are organ supply, monetary cost, and the burden of lifelong immunosuppression. Hepatocyte transplantation, as a substitute for OLT, has been an exciting topic of investigation for several decades. HT is potentially minimally invasive and can serve as a vehicle for delivery of personalized medicine through autologous cell transplant after modification ex vivo. However, 3 major hurdles have prevented large-scale clinical application: (1) availability of transplantable cells; (2) safe and efficient ex vivo gene therapy methods; and (3) engraftment and repopulation efficiency. This review will discuss new sources for transplantable liver cells obtained by lineage reprogramming, clinically acceptable methods of genetic manipulation, and the development of hepatic irradiation-based preparative regimens for enhancing engraftment and repopulation of transplanted hepatocytes. We will also review the results of the first 3 patients with genetic liver disorders who underwent preparative hepatic irradiation before hepatocyte transplantation.
    MeSH term(s) Animals ; Cell Proliferation ; Genetic Therapy ; Hepatocytes/cytology ; Humans ; Liver Transplantation/adverse effects ; Liver Transplantation/methods ; Safety
    Language English
    Publishing date 2018-11-29
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 197614-x
    ISSN 1879-355X ; 0360-3016
    ISSN (online) 1879-355X
    ISSN 0360-3016
    DOI 10.1016/j.ijrobp.2018.11.016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Radiation-primed hepatocyte transplantation in murine monogeneic dyslipidemia normalizes cholesterol and prevents atherosclerosis.

    Barahman, Mark / Zhang, Wei / Harris, Hillary Yaffe / Aiyer, Anita / Kabarriti, Rafi / Kinkhabwala, Milan / Roy-Chowdhury, Namita / Beck, Amanda P / Scanlan, Thomas S / Roy-Chowdhury, Jayanta / Asp, Patrik / Guha, Chandan

    Journal of hepatology

    2019  Volume 70, Issue 6, Page(s) 1170–1179

    Abstract: Background & aims: Inherited abnormalities in apolipoprotein E (ApoE) or low-density lipoprotein receptor (LDLR) function result in early onset cardiovascular disease and death. Currently, the only curative therapy available is liver transplantation. ... ...

    Abstract Background & aims: Inherited abnormalities in apolipoprotein E (ApoE) or low-density lipoprotein receptor (LDLR) function result in early onset cardiovascular disease and death. Currently, the only curative therapy available is liver transplantation. Hepatocyte transplantation is a potential alternative; however, physiological levels of hepatocyte engraftment and repopulation require transplanted cells to have a competitive proliferative advantage of over host hepatocytes. Herein, we aimed to test the efficacy and safety of a novel preparative regimen for hepatocyte transplantation.
    Methods: Herein, we used an ApoE-deficient mouse model to test the efficacy of a new regimen for hepatocyte transplantation. We used image-guided external-beam hepatic irradiation targeting the median and right lobes of the liver to enhance cell transplant engraftment. This was combined with administration of the hepatic mitogen GC-1, a thyroid hormone receptor-β agonist mimetic, which was used to promote repopulation.
    Results: The non-invasive preparative regimen of hepatic irradiation and GC-1 was well-tolerated in ApoE
    Conclusions: Significant hepatic repopulation and the cure of dyslipidemia in this model, using a novel and well-tolerated preparative regimen, demonstrate the clinical potential of applying this method to the treatment of inherited metabolic diseases of the liver.
    Lay summary: Hepatocyte transplantation is a promising alternative to liver transplantation for the treatment of liver diseases. However, it is inefficient, as restricted growth of transplanted cells in the liver limits its therapeutic benefits. Preparative treatments improve the efficiency of this procedure, but no clinically-feasible options are currently available. In this study we develop a novel well-tolerated preparative treatment to improve growth of cells in the liver and then demonstrate that this treatment completely cures an inherited lipid disorder in a mouse model.
    MeSH term(s) Acetates/pharmacology ; Animals ; Apolipoproteins E/blood ; Apolipoproteins E/deficiency ; Atherosclerosis/prevention & control ; Cholesterol/blood ; Disease Models, Animal ; Dyslipidemias/therapy ; Female ; Hepatocytes/radiation effects ; Hepatocytes/transplantation ; Hyperlipoproteinemia Type II/therapy ; Male ; Mice ; Mice, Inbred C57BL ; Phenols/pharmacology
    Chemical Substances Acetates ; Apolipoproteins E ; GC 1 compound ; Phenols ; Cholesterol (97C5T2UQ7J)
    Language English
    Publishing date 2019-01-14
    Publishing country Netherlands
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 605953-3
    ISSN 1600-0641 ; 0168-8278
    ISSN (online) 1600-0641
    ISSN 0168-8278
    DOI 10.1016/j.jhep.2019.01.010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Gunn Rats as a Surrogate Model for Evaluation of Hepatocyte Transplantation-Based Therapies of Crigler-Najjar Syndrome Type 1.

    Polgar, Zsuzsanna / Li, Yanfeng / Li Wang, Xia / Guha, Chandan / Roy-Chowdhury, Namita / Roy-Chowdhury, Jayanta

    Methods in molecular biology (Clifton, N.J.)

    2016  Volume 1506, Page(s) 131–147

    Abstract: Liver transplantation has been established as a curative therapy for acute and chronic liver failure, as well as liver-based inherited metabolic diseases. Because of the complexity of organ transplantation and the worldwide shortage of donor organs, ... ...

    Abstract Liver transplantation has been established as a curative therapy for acute and chronic liver failure, as well as liver-based inherited metabolic diseases. Because of the complexity of organ transplantation and the worldwide shortage of donor organs, hepatocyte transplantation is being developed as a bridging therapy until donor organs become available, or for amelioration of inherited liver-based diseases. The Gunn rat is a molecular and metabolic model of Crigler-Najjar syndrome type 1, which is characterized by lifelong unconjugated hyperbilirubinemia due to the lack of uridinediphosphoglucuronate glucuronosyltransferase-1 (UGT1A1)-mediated bilirubin glucuronidation. Gunn rats are convenient for evaluating the effect of hepatocyte transplantation or gene therapy, because the extent of UGT1A1 replacement can be assessed by serial determination of serum bilirubin levels, and excretion of bilirubin glucuronides in bile provide definitive evidence of the function of the transplanted hepatocytes or the effect of gene therapy. The core techniques involved in hepatocyte transplantation in Gunn rats are discussed in this chapter.
    MeSH term(s) Animals ; Bile/chemistry ; Bile Pigments/analysis ; Bilirubin/analogs & derivatives ; Bilirubin/blood ; Bilirubin/metabolism ; Cell Separation/instrumentation ; Cell Separation/methods ; Cell Transplantation/methods ; Chromatography, High Pressure Liquid ; Crigler-Najjar Syndrome/blood ; Crigler-Najjar Syndrome/surgery ; Disease Models, Animal ; Female ; Gene Transfer Techniques ; Genetic Therapy/methods ; Glucuronosyltransferase/genetics ; Glucuronosyltransferase/metabolism ; Hepatocytes/metabolism ; Hepatocytes/transplantation ; Heterozygote ; Homozygote ; Humans ; Hyperbilirubinemia/blood ; Liver/metabolism ; Liver/surgery ; Liver Diseases/metabolism ; Liver Diseases/surgery ; Liver Function Tests ; Male ; Rats ; Rats, Gunn
    Chemical Substances Bile Pigments ; bilirubin glucuronate (27071-67-6) ; UGT1A1 enzyme (EC 2.4.1.-) ; Glucuronosyltransferase (EC 2.4.1.17) ; Bilirubin (RFM9X3LJ49)
    Language English
    Publishing date 2016-10-18
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ISSN 1940-6029
    ISSN (online) 1940-6029
    DOI 10.1007/978-1-4939-6506-9_9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Human Urinary Epithelial Cells as a Source of Engraftable Hepatocyte-Like Cells Using Stem Cell Technology.

    Sauer, Vanessa / Tchaikovskaya, Tatyana / Wang, Xia / Li, Yanfeng / Zhang, Wei / Tar, Krisztina / Polgar, Zsuzsanna / Ding, Jianqiang / Guha, Chandan / Fox, Ira J / Roy-Chowdhury, Namita / Roy-Chowdhury, Jayanta

    Cell transplantation

    2016  Volume 25, Issue 12, Page(s) 2221–2243

    Abstract: Although several types of somatic cells have been reprogrammed into induced pluripotent stem cells (iPSCs) and then differentiated to hepatocyte-like cells (iHeps), the method for generating such cells from renal tubular epithelial cells shed in human ... ...

    Abstract Although several types of somatic cells have been reprogrammed into induced pluripotent stem cells (iPSCs) and then differentiated to hepatocyte-like cells (iHeps), the method for generating such cells from renal tubular epithelial cells shed in human urine and transplanting them into animal livers has not been described systematically. We report reprogramming of human urinary epithelial cells into iPSCs and subsequent hepatic differentiation, followed by a detailed characterization of the newly generated iHeps. The epithelial cells were reprogrammed into iPSCs by delivering the pluripotency factors OCT3/4, SOX2, KLF4, and MYC using methods that do not involve transgene integration, such as nucleofection of episomal (oriP/EBNA-1) plasmids or infection with recombinant Sendai viruses. After characterization of stable iPSC lines, a three-step differentiation toward hepatocytes was performed. The iHeps expressed a large number of hepatocyte-preferred genes, including nuclear receptors that regulate genes involved in cholesterol homeostasis, bile acid transport, and detoxification. MicroRNA profile of the iHeps largely paralleled that of primary human hepatocytes. The iHeps engrafted into the livers of Scid mice transgenic for mutant human SERPINA1 after intrasplenic injection. Thus, urine is a readily available source for generating human iHeps that could be potentially useful for disease modeling, pharmacological development, and regenerative medicine.
    MeSH term(s) Animals ; Cell Differentiation/genetics ; Cell Differentiation/physiology ; Cells, Cultured ; Epithelial Cells/cytology ; Epithelial Cells/metabolism ; Flow Cytometry ; Hepatocytes/cytology ; Hepatocytes/metabolism ; Humans ; Immunohistochemistry ; Induced Pluripotent Stem Cells/cytology ; Induced Pluripotent Stem Cells/metabolism ; Karyotyping ; Mice ; Mice, Transgenic ; MicroRNAs/genetics ; Reverse Transcriptase Polymerase Chain Reaction ; Urothelium/cytology
    Chemical Substances MicroRNAs
    Language English
    Publishing date 2016-12-13
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1135816-6
    ISSN 1555-3892 ; 0963-6897
    ISSN (online) 1555-3892
    ISSN 0963-6897
    DOI 10.3727/096368916X692014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Nuclear receptors orchestrate detoxification pathways.

    Roy-Chowdhury, Jayanta / Locker, Joseph / Roy-Chowdhury, Namita

    Developmental cell

    2003  Volume 4, Issue 5, Page(s) 607–608

    Abstract: Two nuclear receptors of xenobiotic drugs, PXR and CAR, are central regulators of detoxification enzymes. New studies extend the role of these receptors to a natural detoxification process. They coordinate induction of proteins for storage, ... ...

    Abstract Two nuclear receptors of xenobiotic drugs, PXR and CAR, are central regulators of detoxification enzymes. New studies extend the role of these receptors to a natural detoxification process. They coordinate induction of proteins for storage, glucuronidation, and canalicular transport of bilirubin.
    MeSH term(s) Animals ; Bilirubin/metabolism ; Glucuronosyltransferase/metabolism ; Humans ; Inactivation, Metabolic ; Pregnane X Receptor ; Receptors, Cytoplasmic and Nuclear/metabolism ; Receptors, Steroid/metabolism ; Transcription Factors/metabolism
    Chemical Substances Pregnane X Receptor ; Receptors, Cytoplasmic and Nuclear ; Receptors, Steroid ; Transcription Factors ; constitutive androstane receptor (438XLITDI3) ; UGT1A1 enzyme (EC 2.4.1.-) ; Glucuronosyltransferase (EC 2.4.1.17) ; Bilirubin (RFM9X3LJ49)
    Language English
    Publishing date 2003-04-11
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 2054967-2
    ISSN 1878-1551 ; 1534-5807
    ISSN (online) 1878-1551
    ISSN 1534-5807
    DOI 10.1016/s1534-5807(03)00131-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Ex vivo gene transfer into hepatocytes.

    Wang, Xia / Mani, Prashant / Sarkar, Debi P / Roy-Chowdhury, Namita / Roy-Chowdhury, Jayanta

    Methods in molecular biology (Clifton, N.J.)

    2009  Volume 481, Page(s) 117–140

    Abstract: Ex vivo gene transfer into hepatocytes could serve several purposes in the context of gene therapy or cell transplantation: (1) isolated hepatocytes can be transduced in culture with therapeutic genes and then transplanted into the recipient; (2) marker ... ...

    Abstract Ex vivo gene transfer into hepatocytes could serve several purposes in the context of gene therapy or cell transplantation: (1) isolated hepatocytes can be transduced in culture with therapeutic genes and then transplanted into the recipient; (2) marker genes can be introduced for subsequent identification of transplanted cells and their progeny; (3) gene transfer can be used for conditional immortalization of hepatocytes for expansion in culture; (4) immunomodulatory genes can be transferred into hepatocytes to prevent allograft rejection. Gene transfer into cultured hepatocytes can be achieved using DNA that is not incorporated into recombinant viruses. In such systems, transgene integration into the host cell genome can be enhanced using transposon systems, such as "sleeping beauty." In addition to using the conventional reagents, such as cationic liposomes, DNA transfer into hepatocytes can be achieved by Nucleofection or special hepatocyte-targeted carriers such as proteoliposomes containing galactose-terminated glycoproteins (e.g. the F protein of the Sendai virus). Alternatively, genes can be transferred using recombinant viruses, such as adenoviral vectors that are episomal or retroviral vectors (including lentiviruses) that permit integration of the transgene into the host genome. Gene transfer using lentiviral vectors has been achieved in both attached and suspended hepatocytes. Transduction efficiency of lentiviral vectors can be enhanced using magnetic nanoparticles (Magnetofection).
    MeSH term(s) Animals ; Cell Line, Transformed/cytology ; Gene Transfer Techniques ; Genetic Therapy/methods ; Hepatocytes/cytology ; Hepatocytes/metabolism ; Hepatocytes/transplantation ; Humans ; Liver Transplantation/methods ; Magnetics/methods ; Models, Biological ; Nanoparticles/therapeutic use ; Staining and Labeling/methods ; Transplantation Conditioning/methods
    Language English
    Publishing date 2009
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ISSN 1064-3745
    ISSN 1064-3745
    DOI 10.1007/978-1-59745-201-4_11
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top